Anti-arrhythmic drugs Flashcards

1
Q

Phases of action potential(AP) (atria&
ventricles):
• Phase —: rapid depolarization with fast influx of
Na+→ Na+ channels are rapidly inactivated.
——————- determines
conduction —————–

A

0
Maximal rate of dep. (Vmax)
velocity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Phases of action potential(AP) (atria&
ventricles):
• Phase ————-: early fast repolarization: rapid out flux of————.

A

1
repolarization
K+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

the most effective

A

Amiodarone(cordarone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Phase ————: delay in repolarization (plateau) slow

Ca++ influx &————- K+ efflux

A

2

equal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Phase 3: rapid repolarization due to———— out flux

A

K+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

someone has sever bradycardia what should he use ?

A

Atropine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Phase 4: ———– → Resting membrane
potential (diast.) due to active pump of Ca++&Na+
in exchange of K+

A

full repolarization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pathophysiology of dysrhythmia:
• there is an abnormality in the ———– of origin of the impulse, its rate or
regularity, or its ————-.

A

site

conduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

I. Disturbance in impulse generation
1. Increased automaticity of automatic tissue (↑———–
Depolarization) {e.g. with increased sympathetic Activity}→——————-

A

slope of diastolic

tachyarrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

I.Disturbance in impulse generation
. Decreased automaticity of automatic tissue→ ————–
(↑————tone).

A

Brady arrhythmia

vagal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

I. Disturbance in impulse generation
Development of automaticity in ———- tissues (ectopic
pace-maker or slow responses) due to that, cell remain partially depolarized (Slow diastolic depolarization) as in ————, ————–,
————– Stimulation).

A

non automatic
ischemia
digitalis
sympathetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

II. Disturbance in conduction:
———–: one impulse re-enters and excites the heart more than once.
• -Normally (in some areas) cardiac impulse bifurcates into two branches in order to supply the entire ventricle.
• -These branches conduct at ——- velocities. Then meet and extinguish one another and never re-enters point of bifurcation.

A

Re-entry

equal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Enumerate in order drug used in cardiac arrhythmia ?
1- ————————–dec. slope of phase 4
2—————————dec slope of phase 4 and slow AV conduction
3- ———————–inc. ERF (Duration of action potential
4- ————————–dec. slope of phase 4 and slow AV conduction
5- ————————–dec. slope of phase 4 ,slow AV conduction,hyperpolarization (Dec. RMP) and___________Trap Na+ channel in inactive
state for longer time

A
1- Sodium Channel Blocker
2- Beta Blocker
3-Potassioum channel Blocker
4- Calcium channel Blocker
5-Miscellneous ( Adenosine) and (Mg++)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

•Enumerate the Mechanism of action of anti-arrhythmic drugs

5 tings

A

1•-They restore normal rhythm, decrease ectopic pacemaker activity and block re-entry through:
• -Blockade of Na, K & Ca channels.
• - Decrease cardiac sympathetic activity.
• -Prolongation of refractoriness.
• -↑ dose, normal tissue is affected → arrhythmia (proarrythmogenic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Class 1 Membrane stabilizers ; Sodium channel blockers

A
  • -Block Na channels →slows the rate of rise of phase 0 of the action potential thus ↓ maximal rate of depolarization (Vmax) → ↓conduction velocity (CV) & ↓ excitability.
  • -Inhibit spontaneous diastolic depolarization of automatic tissue → ↓rate of discharge.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Classification of Class 1 according to Effect on APD & CV:
• 1a: ——————-Moderate,inc. ERF
• 1b: —————-Weak,De. ERF
• 1c: —————Strong

A

quinidinen
lidocaine ,mexiletine
Flecainide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Class II = Beta Adrenoceptors blockers (———

,———–, ————–):

A

propranolol-metoprolol-esmolol

18
Q

Mechanisms of Beta Blocker

3 things

A

1• Block intrinsic sympathetic activity → ↓ slope of phase 4 spontaneous depolarization of
automatic tissue.
2• Protect against sympathetic induced ectopic pacemaker activity.
3• - Prolong AV conduction and decreasing HR &
contractility.

19
Q

Class III = K Channel blockers (———&————) :
mechanism 1 things

A

amiodarone -sotalol

• Delay repolarization → ↑ APD → ↑ ERP → block re- entry.

20
Q

Class IV = Ca Channel blockers (————):

mechanism 3 things

A

verapamil
• - Block slow Ca current (slow conduction):
• 1- Slow SAN firing rate & AVN conduction.
• 2- Suppress slow responses (ectopic pacemaker activity).
• 3- Decrease slope of phase 4 depolarization of
automatic tissues.

21
Q

Mechanism of Class IA of Sodium channel blocker?

A

Moderate block on Na+ channel (phase 0)
• Slow conduction velocity
• Prolong ERP (more time between depolarization (i.e.,
more time between heartbeats) _dec HR

22
Q

Quinidine
Autonomic effects:
Therapeutic uses:4
Adverse effects:5 Adverse effects

A

1- atropine – like action, α- blocking activity,
slight negative inotropic effect.
2–Broad spectrum oral drug especially effective in AF or flutter refractory to other agents. But never alone because it increases AV conduction and HR {can induce tachycardia in
normal individuals (atropine- like action)}
• - Re-entry arrhythmias
Adverse effects:
• - Serious effects, largely replaced by verapamil.
• 1- Cardio toxicity: Quinidine syncope or sudden arrythmogenic
death.
• - Vent. Tachycardia hence digitalis or verapamil are given
before quinidine in AF or flutter to block AVN conduction.
• 2- Cinchonism (headache, blurred vision, tinnitus, disorientation
and psychosis).
• 3- GIT upset.
• 4- Thrombocytopenia.
• 5- ↑ serum level of digitalis (↓ clearance).

23
Q

Quinidine never use alone why ?

A

because it increases AV conduction and HR {can induce tachycardia in normal individuals (atropine- like action)}

24
Q
Procainamide (class Ia): 
• Na channel blocker
2 Adverse effects
A

• Therapeutic uses:
• - Broad spectrum, especially used in treatment of ventricular arrhythmia during myocardial infarction.
• -Rarely used due to development of systemic Lupus Erythematosis( up to 30%) and CHF (-ve inotropic),sever hypotension and CNS adverse
effects(depression, psychosis and hallucinations).

25
Disopyramide (class Ia): ?
Similar to quinidine with marked anticholinergic & -ve inotropic effects. • -Broad spectrum used in ventricular, supraventricular, WPW syndrome • - Contraindicated in CHF. • NB: hyperkalemia increases conduction toxicity of class I , which is treated by sodium lactate.
26
Lowest potency to block Na+ channel • Shorten repolarization
Class Ib
27
``` Lidocaine (class IB): 4 things ```
• -Na channel blocker. • -No effect on atrial or AVN conduction → ineffective in supraventricular arrhythmias (AF, Flutter, SVT). • -selective on chronically depolarized ventricular tissue in myocardial ischemia and digitalis toxicity. • Given parentally only.
28
Adverse effects of Lidocaine | 2 things
Adverse effects: • 1- The least cardio toxic antiarrhythmic. But in diseased heart may precipitate heart block. • 2- Parasthesia, tremors, dizziness, slurred speech, disturbed hearing.
29
Most potent block Na+ channel • Markedly slow the rate of depolarization •No change in ERP • They should be used with caution
Class IC
30
Flecainide & Propafenone (class IC) Mechanism of action 1thing Clinical uses 3 things
 It interacts slowly with Na+ channels  Clinical Uses • - Used in SV arrhythmia, and ventricular arrhythmia (if no HF). • - Pro-arrythmogenic (5-12%) → ↑ mortality, AV block, HF; so are restricted to case not responding to other drugs( class IC is of serious toxicity) -They are the most dangerous anti-arrhythmic class of drugs; use only by experienced providers
31
Class II : β1-blockers
- Decrease sympathetic stimulation - They block β1 adrenergic receptors at SA and AV nodes - Decrease the slope of phase 4; take longer time to hit threshold - decrease Frequency of SA firing and slow av conduction so dec HR
32
``` β adrenoceptors blockers (class II agents ) Use of propranolol and metoprolol 2 things Use of Esmolol 1 thing ```
Therapeutic uses: • (propranolol and metoprolol): • Supraventricular dysrhythmias particularly those associated with increased sympathetic activity. • - Prophylactic (to prevent ventricular dysrhythmias) following myocardial infarction → ↓ incidence of CHF and sudden arrythmogenic death. • - Esmolol (an ultashort acting) is used IV in acute arrhythmias during surgery or emergency.
33
• Work primarily on non-nodal cells • Prolong repolarization (Phase 3) • Prolong ERP; more time between depolarization (i.e., more time between heartbeats) • Prolong the action potential
Class III: K+ channel blockers
34
Amiodarone Mechanism 1 thing Uses
• - Heavily iodinated drug. • Broad spectrum. • The most efficacious antidysrhythmic drug. • - Block K channels delaying repolarization →prolongation of APD and ERP. • - Na channel & a weak Ca channel blocker and β receptor blocker (I, IV & II respectively). • - Slows sinus rate and AVN conduction. - Used in Re-entry arrhythmia (Wolff Parkinson White Syndrome). - High lipid soluble drug, precipitate in many adipose tissues, cardiac and skeletal muscle, liver, lung and the thyroid.
35
Adverse effects of Amiodarone ? | 7 things
``` Serious due to long half life →cumulative (t1/2is many weeks with delayed onset). • 1- Alteration of thyroid function • 2- Precipitation of corneal deposits. • 3- Photosensitivity. • 4- Pulmonary infiltrates and fibrosis. • 5- Proximal myopathy and neuropathy. • 6- AV block, sinus bradycardia. • 7- Potentiates warfarin & ↑ digoxin and quinidine levels. ```
36
Dronedarone
• It was approved by the FDA in 2009. • Less toxic on skin, lung and thyroid gland because it is not have a iodine in its structure. • A methylsulfonamide group is added to reduce solubility in fats • Black box warning in USA, to class IV HF (lipophilicity) • t1/2 = 24 hs • Similar mechanism to amiodarone • Approved now only for atrial fibrillation or flutter
37
Sotalol (class II and III) Uses Adverse effect 1
• -Broad spectrum in SV and ventricular arrhythmias &WPW syndrome. • -Long term therapy to decrease incidence of sudden death following myocardial infarction • - Has a strong antifibrillary effects particularly in ischemic myocardium. • -Adverse effects: • had the lowest rate of acute and long term complications. Prolongs QT interval as drugs in class I & syndrome of Torsade de pointes is a serious complication.
38
Non-dihyropyridine (working on SA and AV nodes) e.g., Verapamil, Diltiazem • Slow phase 4 depolarization • Slow AV conduction (prolong repolarization at AV node)
Class IV: Ca++ channel blockers
39
Calcium channel blockers (Verapamil and Diltiazem (classIV) | Therapeutic uses
1- Supraventricular tachycardia (prophylaxis inhibits nodal re-entry). • 2- reduce ventricular rate in AF and flutter. • CI: in CHF due to their –ve inotropic activity.
40
Mechanism of Adenosine and uses
• K channel opener → prolong refractory period and slows CV of AVN. • -Dilates coronary and peripheral blood vessels. • - The drug of choice in acute paroxysmal SV tachycardia. • - Can cause brochospasm ,flushing, headache, chest pain, AV block and hypotension. (CI in asthma and heart block),
41
Uses of digoxin
Digoxin: | • Controls ventricular response in AF and flutter